We use our proprietary vaccine platform technology to develop vaccines against difficult antigens for animal health.
We are a service-oriented technology company that works with our partners to develop best in class animal health vaccines with the goal of long-term, joint value creation.
We offer collaborations and license agreements to industrial partners to develop prophylactic and therapeutic vaccines for companion animals and livestock for
June 1, 2017
Angothera is covered in the June 2017 edition of Biopharma Dealmakers, the partnering supplement to Nature Biotechnology and Nature Reviews Drug Discovery
April 14, 2017
Angothera and The Antibody Lab collaborate on the rapid development of animal health vaccines
Nov 22, 2016
Angothera and OncoQR sign License agreement on veterinary use of S-TIR™ vaccine technology
Sep 1, 2015.
The Antibody Lab GmbH inlicenses Angothera's rights to recombinant Secretory
The Antibody Lab has signed a license agreement with Angothera GmbH on the use and commercial exploitation of Angothera's IP-Rights on recombinant Secretory Component.